Journal of Gynecologic Oncology

Papers
(The TQCC of Journal of Gynecologic Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer38
The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer25
Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis22
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial22
FIGO staging of endometrial cancer: 202322
Laparoscopic vs. robotic-assisted laparoscopy in endometrial cancer staging: large retrospective single-institution study20
Major clinical research advances in gynecologic cancer in 202020
Comparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size <2 cm cervical cancer with visible or invisible tumors: a multicentre retrospective study19
Major clinical research advances in gynecologic cancer in 202118
PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies18
Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer17
Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis17
Safety and efficacy of 3D-printed templates assisted CT-guided radioactive iodine-125 seed implantation for the treatment of recurrent cervical carcinoma after external beam radiotherapy17
Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01)17
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)16
Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome15
MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas14
The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer14
Recurrence risk factors in stage IA grade 1 endometrial cancer14
Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway14
Association of menopause, aging and treatment procedures with positive margins after therapeutic cervical conization for CIN 3: a retrospective study of 8,856 patients by the Japan Society of Obstetri13
Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis13
LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis13
Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma12
Total laparoscopic vs. conventional open abdominal nerve-sparing radical hysterectomy: clinical, surgical, oncological and functional outcomes in 301 patients with cervical cancer12
Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset12
The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis12
Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study12
The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer12
Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment12
A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer11
Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR)10
Financial toxicity in patients with gynecologic malignancies: a cross sectional study10
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic10
Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer9
The prognostic significance of tumor-infiltrating lymphocytes in cervical cancer9
Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol 9
Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005–20209
Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)9
Fertility-sparing surgery for women with stage I cervical cancer of 4 cm or larger: a systematic review8
Lymphadenectomy issues in endometrial cancer8
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Onco7
Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy7
The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines e7
Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women7
Cancer field surgery in endometrial cancer: peritoneal mesometrial resection and targeted compartmental lymphadenectomy for locoregional control7
TP53 variants in p53 signatures and the clonality of STICs in RRSO samples7
Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary per7
Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review7
Why was GOG-0213 a negative trial?7
Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients7
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer7
Diagnostic performance of microRNA-34a, let-7f and microRNA-31 in epithelial ovarian cancer prediction7
Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling7
Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer7
Current status and future directions of ovarian cancer prognostic models6
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer6
Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer6
Rectosigmoid resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer: morbidity of gynecologic oncology vs. colorectal team6
Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes6
Impact of metformin on survival outcome in ovarian cancer: a nationwide population-based cohort study6
An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva6
Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA: first results from the multicentric TMMR register study6
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999–2018 from the national cancer registry6
Conditional relative survival of cervical cancer: a Korean National Cancer Registry Study6
Preclinical investigation of patient-derived cervical cancer organoids for precision medicine6
Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients withBRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemother6
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis6
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial6
Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study5
Early-stage epithelial ovarian cancer: is systematic lymph node staging mandatory?5
Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma5
Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study5
Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer5
Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 20205
The first-round results of a population-based cohort study of HPV testing in Japanese cervical cancer screening: baseline characteristics, screening results, and referral rate5
Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group5
Mapping the robotic hysterectomy learning curve and re-establishing surgical training metrics5
Real-time intraoperative ureter visualization with a novel Near-Infrared Ray Catheter during laparoscopic hysterectomy for gynecological cancer5
A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study5
Molecular classification of endometrial cancer: entering an era of precision medicine5
Comments on the utilization of Mann-Whitney U test and Kaplan-Meier method4
Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study4
Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma4
Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy4
Peripheral bloodBRCA1methylation profiling to predict familial ovarian cancer4
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the 4
Epidemiologic study on gestational trophoblastic diseases in Japan4
The extent of aortic lymphadenectomy in locally advanced cervical cancer impacts on survival4
A novel gene signature associated with poor response to chemoradiotherapy in patients with locally advanced cervical cancer4
Protective ostomies in ovarian cancer surgery: a systematic review and meta-analysis4
Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritone4
Implementation and evaluation of a novel subspecialty society fellows robotic surgical course: the SGO minimally invasive academy surgical curriculum4
Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program4
Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis4
Prognosis in primary mucinous ovarian carcinoma: focusing on the five pathological findings indicating metastatic mucinous carcinoma to the ovary4
Effectiveness of craniotomy and long-term survival in 35 patients with gestational trophoblastic neoplasia with brain metastases: a clinical retrospective analysis4
PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia4
Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea4
Trend analysis of process quality indicators for the Korean National Cervical Cancer Screening Program from 2005 to 20134
Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)4
What is the prognostic importance of lymphovascular space invasion in the absence of lymph node metastasis for early-stage endometrial cancer?4
Time for enhancing government-led primary prevention of cervical cancer4
Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study4
0.025499105453491